Search clinical trials for: Epoetin alfa and Darbepoetin alfa

Total 3149 results

Cadila Pharnmaceuticals

Completed

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

Anemia

India
Seoul National University Bundang Hospital

Completed

The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

Acute Myocardial Infarction

Korea, Republic of
University Medical Center Groningen
Radboud University Medical Center

Unknown

Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model (IPIIR)

Myocardial Infarction | Ischemia-Reperfusion Injury

Netherlands
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy

Anemia

Italy
Hoffmann-La Roche

Terminated

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Anemia

Venezuela
Hoffmann-La Roche

Terminated

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Anemia

Venezuela
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Chronic Kidney Disease (CKD)

United States, Puerto Rico
Hoffmann-La Roche

Completed

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

Anemia

Spain, United States, Czech Republic, Canada, Greece, Switzerland, Thailand, Poland, Russian Federation, Sweden, South Africa, Norway, Brazil
Saint-Joseph University

Terminated

Erythropoietin Role in Acute Kidney Injury (EAKI)

Anemia Renal

Lebanon
Seoul National University Hospital

Withdrawn

Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients

Autoimmune Encephalitis

Korea, Republic of
Zhengzhou University
Göteborg University; Medical University Innsbruck; Zhengzhou Children's Hospital...

Completed

Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy

Hypoxic-Ischemic Encephalopathy

China
University of Calgary
Ortho Biotech, Inc.; Calgary Health Region

Completed

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

Brain Injury | Cardiac Surgery

Canada
Second Affiliated Hospital, School of Medicine,...
Zhejiang Cancer Hospital; First People's Hospital of Hangzhou; Ningbo Medical... and other collaborators

Recruiting

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

Lymphoma | Anemia

China
Second Xiangya Hospital of Central South University

Not yet recruiting

Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients

Anemia in Incident Dialysis Patients

China
Tehran University of Medical Sciences

Unknown

Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients (EPREX)

Multiple Trauma

Iran, Islamic Republic of
Hospices Civils de Lyon

Withdrawn

TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study (TETRAM2)

Spinal Trauma With Neurological Deficit
Sunnybrook Health Sciences Centre
Ortho Biotech, Inc.

Terminated

Erythropoietin Spinal Cord Compression Randomized Trial

Nerve Compression Syndromes

Canada
PT Kalbe Genexine Biologics
Novotech (Australia) Pty Limited

Completed

A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient

Anaemia Associated With Chronic Kidney Disease

Taiwan, Australia, Korea, Republic of, Thailand, Malaysia, Philippines, Indonesia
Hoffmann-La Roche

Completed

A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

Anemia

Italy, Spain, France, Canada, Hungary, United States, Germany, Belgium, Poland, Australia, Israel, United Kingdom, Czech Republic
Translational Research Center for Medical Innovation...
Showa University School of Medicine

Completed

PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease (PREDICT)

Diabetes | Chronic Kidney Disease

Japan
Amgen

Completed

Anemia in Patients With a Non-Myeloid Malignancy

Neoplasms | Anemia
Hoffmann-La Roche

Completed

A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.

Anemia

Serbia
Hoffmann-La Roche

Completed

A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.

Anemia

China
Shahid Beheshti University of Medical Sciences

Enrolling by invitation

The Effect of Erythropoietin in the Treatment of Scleral Necrosis

Conjunctival and Scleral Avascular Lesions

Iran, Islamic Republic of
Bundang CHA Hospital

Completed

Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy

Cerebral Palsy
FibroGen

Completed

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

Anemia

China
North Texas Veterans Healthcare System

Completed

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

Acute Kidney Injury

United States
Lars Vedel Kessing, professor, MD, DMSc.
Novo Nordisk A/S; University of Oxford; The Ministry of Science, Technology and... and other collaborators

Completed

Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder

Mood Disorders

Denmark
Hoffmann-La Roche

Completed

A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia

Anemia

Turkey
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG

Completed

Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant (Neo-PDGF)

Kidney Failure

France
University Hospital, Basel, Switzerland

Completed

Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction (BEATSTEMIPi)

Acute Myocardial Infarction

Switzerland
Amgen

Completed

STAAR-3 Clinical Study

Chronic Kidney Disease | Chronic Renal Insufficiency | Kidney Disease | Pre-dialysis | Pre-ESRD
Amgen

Completed

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Cancer | Non-Myeloid Malignancies
Mirhashemi, Ramin, M.D.

Unknown

Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?

Anemia | Cervix Neoplasms

United States
Hoffmann-La Roche

Completed

A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

Anemia

China, Hong Kong
Amgen

Completed

STAAR-2 Clinical Study

Chronic Kidney Disease | Chronic Renal Insufficiency | Kidney Disease | Pre-dialysis | Pre-ESRD
GlaxoSmithKline

Active, not recruiting

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Neoplasms

Spain, Netherlands, United States, Japan, France, Australia, Korea, Republic of, Canada
Alexandria University

Completed

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Optic Atrophy

Egypt
Bundang CHA Hospital
LG Life Sciences

Completed

Erythropoietin Therapy for Children With Cerebral Palsy

Cerebral Palsy

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Anemia

Italy
Aarhus University Hospital

Completed

Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

Insulin Sensitivity

Denmark
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Hemodialysis Patients

Hemodialysis Patients

Japan
Imperial College London

Recruiting

Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) (EMBRACE)

Encephalopathy | Erythropoietin | Newborn Asphyxia

Bangladesh, India, Sri Lanka
Lars Vedel Kessing
Lundbeck Foundation; Mental Health Services in the Capital Region, Denmark

Completed

Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders (PreTEC-EPO)

Cognitive Impairment | Bipolar Disorder | Unipolar Depression

Denmark
Thomas Jefferson University

Completed

Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

HIV Infections | Acquired Immunodeficiency Syndrome | Hematologic Diseases | Anemia | Blood Disease
Medgenics Medical Israel Ltd.

Completed

Safety and Efficacy of Sustained Erythropoietin Therapy

Anemia

Israel
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Anemia | Lung Cancer

United States
Hoffmann-La Roche

Completed

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis (ALTITUD)

Anemia, Kidney Disease, Chronic

Mexico
Hoffmann-La Roche

Completed

A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis

Anemia

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients

Anemia

Philippines

Search clinical trials for: Epoetin alfa and Darbepoetin alfa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations